This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CSF2. Atinumab is an immunomodulator. It binds to reticulon 4.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Anti-Human CSF2 Recombinant Antibody (Namilumab)Recombinant monoclonal antibody to CSF2. Atinumab is an immunomodulator. It binds to reticulon 4.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
PABL-481 | Human Anti-CSF2 Recombinant Antibody (clone MB007) | Neut | Human IgG |
FN-240CQ | Mouse Anti-Csf2 Recombinant Antibody (clone CBL-1345) | Block, FuncS | Mouse IgG1, κ |
FAMAB-0330JF | Mouse Anti-CSF2 Recombinant Antibody (clone 196) | WB, ELISA, IHC, IF | Mouse IgG |
VS3-WK1680 | Recombinant Rabbit Anti-CSF2 Capture Antibody (clone R06-1A1) | ELISA | Rabbit IgG |
VS3-WK1681 | Recombinant Rabbit Anti-CSF2 Detection Antibody (clone R08-2Y7) | ELISA | Rabbit IgG |
There are currently no Customer reviews or questions for AFC-TAB-259. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.